Compare GSK plc (GSK) vs United States Oil ETF (USO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs United States Oil ETF — how do they compare? GSK plc trades at $46.6 (market cap $91.88B), while United States Oil ETF trades at $147.65 (market cap $1.90B). The key difference: GSK plc is far larger — about 48.4× United States Oil ETF's market cap, and GSK plc pays a 3.9% dividend while United States Oil ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold GSK plc for 93 Days and United States Oil ETF for 21 Days on average.
| GSK | USO | |
|---|---|---|
Market Cap | $91.88B | $1.90B |
Volume | 7,730,529 | 5,932,922 |
Sector | Health | — |
52-Week High | $61.18 | $161.86 |
52-Week Low | $43.24 | $66.17 |
Typical Hold Time | 93 Days | 21 Days |
Enterprise Value | $111.88B | — |
Dividend Yield | 3.9% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $46.45, down 1.21% with bearish technical signals. The company shows strong fundamentals with revenue growth to $32.67B in 2025 and consistent earnings beats. Valuation metrics appear reasonable with P/E of 14.89 and EV/EBITDA of 8.75. Recent developments include strategic oncology partnerships and a $750M cancer therapy acquisition, positioning for long-term growth despite near-term technical weakness.
GSK presents a mixed outlook with strong profitability and pipeline expansion offset by technical bearishness and HIV patent concerns. The company's 29.73% ROE and recent earnings outperformance support investment appeal, while the bearish moving average signal and competitive pressures warrant caution. Analyst consensus leans hold with 55% neutral rating, suggesting balanced risk-reward for long-term investors.
USO is trading at $148.32, up 3.06% today with a bullish technical signal supported by moving averages. The stock shows neutral oscillator readings with RSI at 63.03 suggesting balanced momentum. Recent news highlights oil market volatility from Middle East tensions and OPEC+ production decisions, creating both supply risks and price pressures.
The outlook remains cautiously optimistic given geopolitical tensions supporting oil prices, though G7 reserve releases and potential supply disruptions create conflicting forces. Key resistance sits at $150 with support at $146, making current levels critical for near-term direction amid volatile energy market conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About United States Oil ETF
This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →
